CERo Therapeutics Holdings Inc (NASDAQ:CERO) currently has a daily average trading volume of 1.07M but it saw 5816047 shares traded in last market. With a market cap of 5.43M USD, the company’s current market price of $1.99 came rising about 2.58 while comparing to the previous closing price of $1.94. In past 52 weeks, the stock remained buoying in the range of price level as high as $1280.00 and as low as $1.76. In the recent trading on the day, stock has struck highest price mark of $1.9 while lowest mark touched by it was $3.18.
Taking a look at 20-day trading activity of CERo Therapeutics Holdings Inc (CERO) gives us an average price of $3.2270, while its current price level is -99.84% below from 52-week high level whereas it is 13.07% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $9.3410 while that of 200 days or SMA-200 reads an average of $35.3427. A closer look into the stock’s movement over the week reveals that its volatility is standing at 29.68% during that period while stretching the period over a month that decreases to 27.20%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 33.02 which implies that the stock is in neutral territory.
Over the week, CERO’s stock price is moving -15.32% down while it is -66.83% when we observe its performance for the past one month. Year-to-date it is -66.83% down and over the past year, the stock is showing a downside performance of -99.82%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, CERo Therapeutics Holdings Inc’s total number of outstanding shares is 1.48M with 55.42% of that held by the insiders while 5.08% of its common stock has been owned by the institutions. Company’s return on equity (ROE) at -4090.08%. Stock’s beta reads 0.39. Its return on asset (ROA) is -108.70% on average.
